TFE3 Xp11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease

per Baba, Masaya, Furuya, Mitsuko, Motoshima, Takanobu, Lang, Martin, Funasaki, Shintaro, Ma, Wenjuan, Sun, Hong-Wei, Hasumi, Hisashi, Huang, Ying, Kato, Ikuma, Kadomatsu, Tsuyoshi, Satou, Yorifumi, Morris, Nicole, Karim, Baktiar O., Ileva, Lilia, Kalen, Joseph D., Krisna, Luh Ade Wilan, Hasumi, Yukiko, Sugiyama, Aiko, Kurahashi, Ryoma, Nishimoto, Koshiro, Oyama, Masafumi, Nagashima, Yoji, Kuroda, Naoto, Araki, Kimi, Eto, Masatoshi, Yao, Masahiro, Kamba, Tomomi, Suda, Toshio, Oike, Yuichi, Schmidt, Laura S., Linehan, W. Marston
Publicat a Mol Cancer Res (2019)